EudraCT    European Union Drug Regulating Authorities Clinical Trials    IH1_Z DH_AH0 European Clinical Trials Database AH1_V AO1_L K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z AH1_V IH2_N_V_EH0_S_T_IH0_G_EY1_SH_AH0_N_AH0_L M_AH0_D_IH1_S_AH0_N_AH0_L P_R_AA1_D_AH0_K_T_S W_IH1_DH AE1_T L_IY1_S_T W_AH1_N S_AY1_T IH0_N DH_AH0 European Union K_AH0_M_EH1_N_S_IH0_NG May 2004 AO1_R L_EY1_T_ER0 The EudraCT D_EY1_T_AH0_B_EY2_S HH_AE1_Z B_IH1_N IH0_S_T_AE1_B_L_IH0_SH_T IH0_N AH0_K_AO1_R_D_AH0_N_S W_IH1_DH Directive 2001 20 EC The EudraCT Number IH1_Z Y_UW0_N_IY1_K AH0_N_D IH1_Z N_IY1_D_AH0_D AA1_N AH1_DH_ER0 D_AA1_K_Y_AH0_M_AH0_N_T_S R_IH0_L_EY1_T_IH0_NG T_UW1 DH_AH0 T_R_AY1_AH0_L_Z    IY1 JH_IY1 SUSAR R_IH0_P_AO1_R_T_S The P_AH1_B_L_IH0_K S_AY1_D AH1_V EudraCT IH1_Z F_AO1_R AO2_R_G_AH0_N_IH0_Z_EY1_SH_AH0_N_Z T_UW1 R_EH1_JH_IH0_S_T_ER0 EH1_N_IY0 AH1_V DH_EH1_R K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z AE1_Z D_IH0_F_AY1_N_D B_AY1 Directive 2001 20 EC The P_R_AA1_S_EH2_S AH1_V AH0_P_L_AY1_IH0_NG AH0_N_D R_EH1_JH_IH0_S_T_ER0_IH0_NG AH0 K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L SH_UH1_D B_IY1 K_AH0_M_P_L_IY1_T_AH0_D B_IH0_F_AO1_R S_AH0_B_M_IH1_T_IH0_NG AE1_N AE2_P_L_AH0_K_EY1_SH_AH0_N T_UW1 EH1_N_IY0 AH1_V DH_AH0 Member State EH1_S IH0_N W_IH1_CH DH_EY1 AE0_N_T_IH1_S_AH0_P_EY2_T R_AH1_N_IH0_NG DH_AH0 T_R_AY1_AH0_L The P_AH1_B_L_IH0_K S_AY1_D AH1_V EudraCT D_AH1_Z N_AA1_T S_EY1_V EH1_N_IY0 AH1_V DH_AH0 T_R_AY1_AH0_L D_IH0_T_EY1_L EH1_N_T_ER0_D B_AY1 DH_AH0 Y_UW1_Z_ER0    AH0_N_D IH2_N_S_T_EH1_D P_R_AH0_V_AY1_D_Z AH0 S_EY1_V_D D_EY1_T_AH0 F_AY1_L IH0_N DH_AH0 F_AO1_R_M AH1_V AE1_N XML W_IH1_CH DH_AH0 Y_UW1_Z_ER0 M_AH1_S_T S_T_AO1_R AA1_N DH_EH1_R OW1_N L_OW1_K_AH0_L HH_AA1_R_D D_R_AY1_V Application F_AO1_R AE1_N EudraCT N_AH1_M_B_ER0 IH1_Z M_EY1_D V_AY1_AH0 DH_AH0 EudraCT W_EH1_B_S_AY2_T To JH_EH1_N_ER0_EY2_T DH_AH0 EudraCT N_AH1_M_B_ER0 S_AH1_M B_EY1_S_IH0_K IH2_N_F_AO2_R_M_EY1_SH_AH0_N AH0_B_AW1_T DH_AH0 requestor EH1_S AO2_R_G_AH0_N_IH0_Z_EY1_SH_AH0_N AH0_N_D DH_AH0 T_R_AY1_AH0_L IH1_Z R_IY0_K_W_AY1_ER0_D    Once DH_AH0 requestor S_AH2_B_M_IH1_T_S DH_AH0 F_AO1_R_M    DH_AH0 EudraCT Number W_IH1_L B_IY1 AH0_S_AY1_N_D AH0_N_D AE1_N IY1 M_EY1_L K_AO1_L_D    EudraCT Receipt    S_EH1_N_T The EudraCT N_AH1_M_B_ER0 HH_AE1_Z DH_AH0 F_AO1_R_M_AE2_T YYYY NNNNNN CC    W_EH1_R    The Clinical Trial Application    CTA    F_AO1_R_M IH1_Z AO1_L_S_OW0 K_R_IY0_EY1_T_AH0_D V_AY1_AH0 DH_AH0 EudraCT S_IH1_S_T_AH0_M The EudraCT D_EY1_T_AH0_B_EY2_S IH1_Z K_ER1_AH0_N_T_L_IY0 AA1_N Version Version AH1_V EudraCT W_AA1_Z R_IY0_L_IY1_S_T IH0_N November 2013 New F_IY1_CH_ER0_Z F_AO1_R Version IH2_N_K_L_UW1_D    Protocol R_IH0_L_EY1_T_IH0_D IH2_N_F_AO2_R_M_EY1_SH_AH0_N Sponsors K_AE1_N     PIP addressees K_AE1_N    Result R_IH0_L_EY1_T_IH0_D IH2_N_F_AO2_R_M_EY1_SH_AH0_N Results Y_UW1_Z_ER0_Z K_AE1_N     Source